Effect of surgical mask on exercise capacity in COPD: a randomised crossover trial

Footnotes

This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.

Conflict of Interest Disclosures: KH reports personal fees from AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline outside of the submitted work. AT reports personal fees from AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, KYORIN Pharmaceutical, and Sanofi outside of the submitted work. HS, YS, and YU have nothing to disclose. EI reports personal fees from Bristol-Myers Squibb, Nippontect systems, Pfizer, and RCR outside of the submitted work. HS reports personal fees from AstraZeneca, Boehringer Ingelheim, Kyorin Pharmaceutical, GlaxoSmithKline, Novartis, Sanofi outside of the submitted work.